Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Full-Length and Fragmented Netrin-1 in Multiple Sclerosis Plaques Are Inhibitors of Oligodendrocyte Precursor Cell Migration.
The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.
[Prognostic factors of multiple sclerosis in children and adolescents after the first demyelinating event.]
Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases.
Consistent reduction in the annualized rate of brain volume loss across phase 3 core and extension trials of fingolimod in relapsing multiple sclerosis.
TREM2 Function in Alzheimer's Disease and Neurodegeneration.
Does ability to walk reflect general functionality in inflammatory neuropathies?
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.
Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-beta.
Treatment of neuromyelitis optica.
Reply to Letter to the Editor re: Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a macrocy
IL-11 in multiple sclerosis.
Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.
Myopathy associated with Neuromyelitis Optica Spectrum Disorders.
A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.
Intrinsic third ventricular craniopharyngioma: A case report.
Neuro-immune interactions of neural stem cell transplants: From animal disease models to human trials.
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.
Female sex hormones and cytokine secretion in women with multiple sclerosis.
A tissue-relaxation-dependent neighboring method for robust mapping of the myelin water fraction.
The link between resting-state functional connectivity and cognition in MS patients.
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 9. Therapeutic progress in multiple sclerosis and neuromyelitis optica].
Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis.
A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder.
Concentration of neddylation-related molecules in paranodal myelin of the peripheral nervous system.
Pages
« first
‹ previous
…
631
632
633
634
635
636
637
638
639
…
next ›
last »